SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-18
👔
Mirum Pharmaceuticals, Inc.
@MIRM_InsiderForm 4 Filing: GREY MICHAEL G Acquires (Grant) shares of $MIRM
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Mirum Pharmaceuticals, Inc.
Ticker: $MIRM
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-15
Shares: 5,752
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, GREY MICHAEL G, holds the title of Director at Mirum Pharmaceuticals, Inc..
On 2026-06-15, the insider transacted 5,752 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
GREY MICHAEL G (Director) was granted $0 of $MIRM
Post-Transaction Position: 3,772 shares
SEC Accession No: 0001240122-26-000005 (CIK: 1240122)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.